| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Submitted on March 27, 2002
From the Département de Pharmacologie, Faculté de
Médecine Paris-Sud, INSERM 00-01 (F.T., S.P., J-F.G., C.R-G.), Le
Kremlin-Bicêtre, France; Faculté de Médecine Necker-Enfants
Malades, Université Paris (V A.A.H.), Paris, France; and INSERM U367
(M.B-F., F.A-G., P.M.), Paris,
France. * To whom correspondence should be addressed. E-mail: pmeneton{at}infobiogen.fr
.
AbstractTo
clarify the role of the kallikrein-kinin system in
cardiovascular homeostasis, the systemic and regional
hemodynamics of kinin B2
receptor--deficient
(B2-/-) and
tissue kallikrein--deficient (TK-/-)
mice were compared with their wild-type (WT) littermates on a pure
C57BL/6 genetic background.
B2-/-,
TK-/-, and WT adult mice were
normotensive and displayed normal hemodynamic (left
ventricular [LV] pressure, cardiac output, total
peripheral resistance, dP/dtmax) and
echocardiographic (septum and LV posterior wall
thickness, LV diameter, LV mass, and LV fractional shortening)
parameters. However, heart rate was lower in
B2-/- mice
compared with TK-/- and WT mice. In
addition, B2-/-
mice, but not TK-/- mice, exhibited
lower coronary and renal blood flows and greater corresponding
vascular resistances than did WT mice, indicating a tonic
physiological vasodilating effect of bradykinin in
these vascular beds. However, maximal coronary vasodilatation
capacity, estimated after dipyridamole infusion, was
similar in the 3 groups of mice.
B2-/- mice were
significantly more sensitive than were
TK-/- mice to the vasoconstrictor
effects of angiotensin II and norepinephrine.
Finally, renin mRNA levels were significantly greater in
B2-/- mice and
smaller in TK-/- mice compared with WT
mice. Taken together, these results indicate that under basal
conditions, the kinin B2 receptor is not an
important determinant of blood pressure in mice but is involved in the
control of regional vascular tone in the coronaries and the kidneys.
The phenotypic differences observed between
TK-/- and
B2-/- mice could
be underlain by tissue kallikrein kinin--independent effect and/or
kinin B1 receptor activation.
Revised on April 17, 2002
Cardiovascular Phenotypes
of Kinin B2 Receptor-- and Tissue
Kallikrein--Deficient Mice
Fabien Trabold;
This article has been cited by other articles:
![]() |
M. Bader Kallikrein-Kinin System in Neovascularization Arterioscler Thromb Vasc Biol, May 1, 2009; 29(5): 617 - 619. [Full Text] [PDF] |
||||
![]() |
V. Griol-Charhbili, L. Sabbah, J. Colucci, M.-P. Vincent, V. Baudrie, D. Laude, J.-L. Elghozi, P. Bruneval, N. Picard, P. Meneton, et al. Tissue kallikrein deficiency and renovascular hypertension in the mouse Am J Physiol Regulatory Integrative Comp Physiol, May 1, 2009; 296(5): R1385 - R1391. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Pons, V. Griol-Charhbili, C. Heymes, P. Fornes, D. Heudes, A. Hagege, X. Loyer, P. Meneton, J.-F. Giudicelli, J.-L. Samuel, et al. Tissue kallikrein deficiency aggravates cardiac remodelling and decreases survival after myocardial infarction in mice Eur J Heart Fail, April 1, 2008; 10(4): 343 - 351. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. C. Isbell, S. Voros, Z. Yang, J. M. DiMaria, S. S. Berr, B. A. French, F. H. Epstein, S. P. Bishop, H. Wang, R. J. Roy, et al. Interaction between bradykinin subtype 2 and angiotensin II type 2 receptors during post-MI left ventricular remodeling Am J Physiol Heart Circ Physiol, December 1, 2007; 293(6): H3372 - H3378. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Messadi-Laribi, V. Griol-Charhbili, A. Pizard, M.-P. Vincent, D. Heudes, P. Meneton, F. Alhenc-Gelas, and C. Richer Tissue Kallikrein Is Involved in the Cardioprotective Effect of AT1-Receptor Blockade in Acute Myocardial Ischemia J. Pharmacol. Exp. Ther., October 1, 2007; 323(1): 210 - 216. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Cayla, M. Todiras, R. Iliescu, V. V. Saul, V. Gross, B. Pilz, G. Chai, V. F. Merino, J. B. Pesquero, O. C. Baltatu, et al. Mice deficient for both kinin receptors are normotensive and protected from endotoxin-induced hypotension FASEB J, June 1, 2007; 21(8): 1689 - 1698. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Biyashev, F. Tan, Z. Chen, K. Zhang, P. A. Deddish, E. G. Erdos, and C. Hecquet Kallikrein activates bradykinin B2 receptors in absence of kininogen Am J Physiol Heart Circ Physiol, March 1, 2006; 290(3): H1244 - H1250. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Picard, M. Van Abel, C. Campone, M. Seiler, M. Bloch-Faure, J. G.J. Hoenderop, J. Loffing, P. Meneton, R. J.M. Bindels, M. Paillard, et al. Tissue Kallikrein-Deficient Mice Display a Defect in Renal Tubular Calcium Absorption J. Am. Soc. Nephrol., December 1, 2005; 16(12): 3602 - 3610. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. M. F. Leeb-Lundberg, F. Marceau, W. Muller-Esterl, D. J. Pettibone, and B. L. Zuraw International Union of Pharmacology. XLV. Classification of the Kinin Receptor Family: from Molecular Mechanisms to Pathophysiological Consequences Pharmacol. Rev., March 1, 2005; 57(1): 27 - 77. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. H. Schmaier The kallikrein-kinin and the renin-angiotensin systems have a multilayered interaction Am J Physiol Regulatory Integrative Comp Physiol, July 1, 2003; 285(1): R1 - R13. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. P. Schanstra, J. Duchene, F. Praddaude, P. Bruneval, I. Tack, J. Chevalier, J.-P. Girolami, and J.-L. Bascands Regulation of Cardiovascular Signaling by Kinins and Products of Similar Converting Enzyme Systems: Decreased renal NO excretion and reduced glomerular tuft area in mice lacking the bradykinin B2 receptor Am J Physiol Heart Circ Physiol, June 1, 2003; 284(6): H1904 - H1908. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. D. Xiao, S. Fuchs, J. M. Cole, K. M. Disher, R. L. Sutliff, and K. E. Bernstein Regulation of Cardiovascular Signaling by Kinins and Products of Similar Converting-Enzyme Systems: Role of bradykinin in angiotensin-converting enzyme knockout mice Am J Physiol Heart Circ Physiol, June 1, 2003; 284(6): H1969 - H1977. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Maestri, A. F. Milia, M. B. Salis, G. Graiani, C. Lagrasta, M. Monica, D. Corradi, C. Emanueli, and P. Madeddu Cardiac Hypertrophy and Microvascular Deficit in Kinin B2 Receptor Knockout Mice Hypertension, May 1, 2003; 41(5): 1151 - 1155. [Abstract] [Full Text] [PDF] |
||||
|
Hypertension Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2002 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |